iifl-logo

Johnson Pharmacare Ltd Board Meeting

0.89
(-2.20%)
Jun 2, 2025|01:22:00 PM

Johnson Pharma CORPORATE ACTIONS

02/06/2024calendar-icon
02/06/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting23 May 202512 May 2025
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve PFA This is to inform you that Outcome of the Board Meeting of the Company held on Friday 23rd May 2025 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2025. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2025. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2025 with Unmodified opinion. The board meeting commenced on 05:40 PM and concluded on 06:10 PM. Request you to kindly take on record the same. Thanking You. (As Per BSE Announcement Dated on :23.05.2025)
Board Meeting31 Jan 202521 Jan 2025
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements ) Regul ations 2015 we would like to inform you t hat a meeting of the Board of Directors of the Company will be held on Friday 31st January 2025 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Friday 31st January 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. The board meeting commented at 06:25 PM and concluded at 06:45 PM Please take the above intimation in your records. Thanking You, PFA (As per BSE Announcement Dated on 31/01/2025)
Board Meeting22 Jan 202522 Jan 2025
PFA
Board Meeting13 Nov 202415 Oct 2024
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve PFA Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of t he SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 13th November 2024 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September, 2024. The meeting commenced at 06:15 P.M. and concluded at 06.40P.M. Kindly take the same on your record and oblige. Thanking You (As per BSE Announcement Dated on 13/11/2024)
Board Meeting1 Aug 202425 Jul 2024
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2024. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 01/08/2024)

Johnson Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.